BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31257467)

  • 1. Astragaloside IV inhibits oxidized low‑density lipoprotein‑induced endothelial damage via upregulation of miR‑140‑3p.
    Qian W; Qian Q; Cai X; Han R; Yang W; Zhang X; Zhao H; Zhu R
    Int J Mol Med; 2019 Sep; 44(3):847-856. PubMed ID: 31257467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salidroside attenuates oxidized low‑density lipoprotein‑induced endothelial cell injury via promotion of the AMPK/SIRT1 pathway.
    Zhao D; Sun X; Lv S; Sun M; Guo H; Zhai Y; Wang Z; Dai P; Zheng L; Ye M; Wang X
    Int J Mol Med; 2019 Jun; 43(6):2279-2290. PubMed ID: 30942428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxymatrine attenuates oxidized low‑density lipoprotein‑induced HUVEC injury by inhibiting NLRP3 inflammasome‑mediated pyroptosis via the activation of the SIRT1/Nrf2 signaling pathway.
    Jin X; Fu W; Zhou J; Shuai N; Yang Y; Wang B
    Int J Mol Med; 2021 Oct; 48(4):. PubMed ID: 34368883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of microRNA‑34a inhibits oxidized low‑density lipoprotein‑induced apoptosis and oxidative stress in human umbilical vein endothelial cells.
    Zhong X; Li P; Li J; He R; Cheng G; Li Y
    Int J Mol Med; 2018 Aug; 42(2):1134-1144. PubMed ID: 29750293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosuvastatin protects against oxidized low‑density lipoprotein‑induced endothelial cell injury of atherosclerosis in vitro.
    Geng J; Xu H; Yu X; Xu G; Cao H; Lin G; Sui D
    Mol Med Rep; 2019 Jan; 19(1):432-440. PubMed ID: 30483737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR‑21/PTEN pathway mediates the cardioprotection of geniposide against oxidized low‑density lipoprotein‑induced endothelial injury via suppressing oxidative stress and inflammatory response.
    Zhou S; Sun Y; Zhao K; Gao Y; Cui J; Qi L; Huang L
    Int J Mol Med; 2020 May; 45(5):1305-1316. PubMed ID: 32323738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIRT4 suppresses the PI3K/Akt/NF‑κB signaling pathway and attenuates HUVEC injury induced by oxLDL.
    Tao Y; Yu S; Chao M; Wang Y; Xiong J; Lai H
    Mol Med Rep; 2019 Jun; 19(6):4973-4979. PubMed ID: 31059091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of miR‑590 on oxLDL‑induced endothelial cell apoptosis: Roles of p53 and NF‑κB.
    Bao MH; Li JM; Zhou QL; Li GY; Zeng J; Zhao J; Zhang YW
    Mol Med Rep; 2016 Jan; 13(1):867-73. PubMed ID: 26648441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective Effects of Total Saponins of
    Zhou P; Xie W; Luo Y; Lu S; Dai Z; Wang R; Sun G; Sun X
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SESN1 attenuates the Ox‑LDL‑induced inflammation, apoptosis and endothelial‑mesenchymal transition of human umbilical vein endothelial cells by regulating AMPK/SIRT1/LOX1 signaling.
    Gao F; Zhao Y; Zhang B; Xiao C; Sun Z; Gao Y; Dou X
    Mol Med Rep; 2022 May; 25(5):. PubMed ID: 35293601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astragaloside IV protects endothelial progenitor cells from the damage of ox-LDL via the LOX-1/NLRP3 inflammasome pathway.
    Qian W; Cai X; Qian Q; Zhuang Q; Yang W; Zhang X; Zhao L
    Drug Des Devel Ther; 2019; 13():2579-2589. PubMed ID: 31440038
    [No Abstract]   [Full Text] [Related]  

  • 12. Pro-angiogenic activity of astragaloside IV in HUVECs in vitro and zebrafish in vivo.
    Zhang Y; Hu G; Li S; Li ZH; Lam CO; Hong SJ; Kwan YW; Chan SW; Leung GP; Lee SM
    Mol Med Rep; 2012 Mar; 5(3):805-11. PubMed ID: 22179585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astragaloside IV exerts angiogenesis and cardioprotection after myocardial infarction via regulating PTEN/PI3K/Akt signaling pathway.
    Cheng S; Zhang X; Feng Q; Chen J; Shen L; Yu P; Yang L; Chen D; Zhang H; Sun W; Chen X
    Life Sci; 2019 Jun; 227():82-93. PubMed ID: 31004658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CircUSP36 knockdown alleviates oxidized low‑density lipoprotein‑induced cell injury and inflammatory responses in human umbilical vein endothelial cells via the miR‑20a‑5p/ROCK2 axis.
    Miao J; Wang B; Shao R; Wang Y
    Int J Mol Med; 2021 Apr; 47(4):. PubMed ID: 33576448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of hsa_circ_0001445 reverses oxLDL‑induced inhibition of HUVEC proliferation via SRSF1.
    Liang G; Chen S; Xin S; Dong L
    Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33982782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphocreatine protects endothelial cells from oxidized low-density lipoprotein-induced apoptosis by modulating the PI3K/Akt/eNOS pathway.
    Ahsan A; Han G; Pan J; Liu S; Padhiar AA; Chu P; Sun Z; Zhang Z; Sun B; Wu J; Irshad A; Lin Y; Peng J; Tang Z
    Apoptosis; 2015 Dec; 20(12):1563-76. PubMed ID: 26404526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin‑receptor substrate 1 protects against injury in endothelial cell models of ox‑LDL‑induced atherosclerosis by inhibiting ER stress/oxidative stress‑mediated apoptosis and activating the Akt/FoxO1 signaling pathway.
    Liu J; Yi X; Tao Y; Wang Y; Xu Z
    Int J Mol Med; 2020 Nov; 46(5):1671-1682. PubMed ID: 33000267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astragaloside IV alleviates atherosclerosis through targeting circ_0000231/miR-135a-5p/CLIC4 axis in AS cell model in vitro.
    Shao X; Liu Z; Liu S; Lin N; Deng Y
    Mol Cell Biochem; 2021 Apr; 476(4):1783-1795. PubMed ID: 33439448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astragaloside IV Protects Against Oxidized Low-Density Lipoprotein (ox-LDL)-Induced Endothelial Cell Injury by Reducing Oxidative Stress and Inflammation.
    Zhu Z; Li J; Zhang X
    Med Sci Monit; 2019 Mar; 25():2132-2140. PubMed ID: 30901320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA‑155 promotes ox‑LDL‑induced autophagy in human umbilical vein endothelial cells by targeting the PI3K/Akt/mTOR pathway.
    Yin S; Yang S; Pan X; Ma A; Ma J; Pei H; Dong Y; Li S; Li W; Bi X
    Mol Med Rep; 2018 Sep; 18(3):2798-2806. PubMed ID: 30015881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.